Multipurpose Prevention Technologies for the Developing World: U.S. Investment is Critical

Published in the Guttmacher Policy Review in the summer of 2015, this article makes the case for greater investment in the development of multipurpose prevention technologies (MPTs) that would provide protection against multiple health risks, such as unintended pregnancy, HIV, and sexually transmitted infections. No large pharmaceutical company has a significant program in MPT research, so the development of these promising products depends on support from governments and foundations.

Length: 
8 pages
Year: 
2015
Organization: 
Guttmacher Institute
PATH
CAMI Health
Languages: 
English
Author(s): 
Health D. Boonstra